$1,000 – $3,000 Paid Clinical Trials
440 studies
Standard inpatient Phase 1 studies with multi-day residential stays typically compensate $1,000–$3,000.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 221–240 of 440 studies
Recruiting
Phase 1
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC31 enrolled10 locationsNCT06349473
Recruiting
Phase 1
A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants
Healthy Participants
AC Immune SA78 enrolled1 locationNCT07463196
Recruiting
Phase 1
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
Healthy Volunteers Essential Hypertension
Kyowa Kirin Co., Ltd.160 enrolled3 locationsNCT06823947
Recruiting
Phase 1
A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
Healthy Volunteers
Eisai Inc.10 enrolled1 locationNCT07308236
Recruiting
Phase 1
A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector
ObesityHealthy
Boehringer Ingelheim56 enrolled1 locationNCT07413913
Recruiting
Phase 1
A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
Healthy Volunteers
argenx104 enrolled1 locationNCT07377396
Recruiting
Phase 1
A Phase Ia Clinical Trial of HW241045
Healthy VolunteersIPF
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.56 enrolled1 locationNCT07448194
Recruiting
Phase 1
A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity
ObesityHealthyOverweight
Eli Lilly and Company120 enrolled3 locationsNCT07232732
Recruiting
Phase 1
A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
Healthy VolunteersPrimary Sclerosing Cholangitis
Takeda134 enrolled1 locationNCT07229911
Recruiting
Phase 1
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
Healthy Volunteers
Bristol-Myers Squibb140 enrolled1 locationNCT07226817
Recruiting
Phase 1
A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections
Healthy Volunteer
AbbVie87 enrolled2 locationsNCT07232004
Recruiting
Phase 1
A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)
HealthyHepatic Impairment
Merck Sharp & Dohme LLC58 enrolled3 locationsNCT07219550
Recruiting
Phase 1
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
Healthy Volunteer
Astellas Pharma Global Development, Inc.54 enrolled1 locationNCT07395024
Recruiting
Phase 1
A Study of Remternetug (LY3372993) in Healthy Chinese Participants
Healthy
Eli Lilly and Company24 enrolled2 locationsNCT07346495
Recruiting
Phase 1
A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
Healthy Volunteer
AbbVie40 enrolled2 locationsNCT07413133
Recruiting
Phase 1
A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food
Healthy Participants
AstraZeneca26 enrolled1 locationNCT07404137
Recruiting
Phase 1Phase 2
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Healthy
Johns Hopkins University30 enrolled1 locationNCT05301608
Recruiting
Phase 1
A Study of LY4515100 in Healthy Participants
Healthy
Eli Lilly and Company40 enrolled1 locationNCT07339722
Recruiting
Phase 1
A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants
CancerHealthy
Eli Lilly and Company104 enrolled1 locationNCT07046559
Recruiting
Phase 1
Phase 1 Study of ADX-626 in Healthy Participants
healthy adult participants
ADARx Pharmaceuticals, Inc.44 enrolled1 locationNCT07081503